UTHR logo

United Therapeutics (UTHR) Book Value

Annual Book Value

$5.98 B
+$1.19 B+24.77%

December 31, 2023


Summary


Performance

UTHR Book Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherUTHRbalance sheetmetrics:

Quarterly Book Value

$6.10 B
+$403.70 M+7.09%

September 30, 2024


Summary


Performance

UTHR Quarterly Book Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherUTHRbalance sheetmetrics:

Book Value Formula

Book Value = Total Assets − Total Liabilities

UTHR Book Value Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+24.8%+6.8%
3 y3 years+76.3%+6.8%
5 y5 years+114.6%+106.9%

UTHR Book Value Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+51.2%at high+54.1%
5 y5-yearat high+115.3%at high+119.4%
alltimeall timeat high>+9999.0%at high>+9999.0%

United Therapeutics Book Value History

DateAnnualQuarterly
Sep 2024
-
$6.10 B(+7.1%)
Jun 2024
-
$5.70 B(+6.7%)
Mar 2024
-
$5.34 B(-10.8%)
Dec 2023
$5.98 B(+24.8%)
$5.98 B(+4.8%)
Sep 2023
-
$5.71 B(+5.6%)
Jun 2023
-
$5.41 B(+5.6%)
Mar 2023
-
$5.12 B(+6.8%)
Dec 2022
$4.80 B(+21.2%)
$4.80 B(+5.1%)
Sep 2022
-
$4.56 B(+5.6%)
Jun 2022
-
$4.32 B(+3.4%)
Mar 2022
-
$4.18 B(+5.5%)
Dec 2021
$3.96 B(+16.6%)
$3.96 B(+3.4%)
Sep 2021
-
$3.83 B(+5.2%)
Jun 2021
-
$3.64 B(+5.6%)
Mar 2021
-
$3.45 B(+1.5%)
Dec 2020
$3.40 B(+22.1%)
$3.40 B(+3.4%)
Sep 2020
-
$3.28 B(+6.1%)
Jun 2020
-
$3.09 B(+4.9%)
Mar 2020
-
$2.95 B(+6.0%)
Dec 2019
$2.78 B(-0.3%)
$2.78 B(+2.4%)
Sep 2019
-
$2.72 B(+6.2%)
Jun 2019
-
$2.56 B(+10.3%)
Mar 2019
-
$2.32 B(-16.8%)
Dec 2018
$2.79 B(+32.7%)
$2.79 B(+3.6%)
Sep 2018
-
$2.69 B(+5.0%)
Jun 2018
-
$2.57 B(+8.3%)
Mar 2018
-
$2.37 B(+12.7%)
Dec 2017
$2.10 B(+13.5%)
$2.10 B(+1.5%)
Sep 2017
-
$2.07 B(+16.5%)
Jun 2017
-
$1.78 B(-14.0%)
Mar 2017
-
$2.07 B(+11.6%)
Dec 2016
$1.85 B(+16.5%)
$1.85 B(+0.7%)
Sep 2016
-
$1.84 B(+1.8%)
Jun 2016
-
$1.81 B(+5.5%)
Mar 2016
-
$1.71 B(+7.8%)
Dec 2015
$1.59 B(+27.9%)
$1.59 B(+8.3%)
Sep 2015
-
$1.47 B(+41.0%)
Jun 2015
-
$1.04 B(-4.7%)
Mar 2015
-
$1.09 B(-12.1%)
Dec 2014
$1.24 B(-1.3%)
$1.24 B(+5.3%)
Sep 2014
-
$1.18 B(+0.6%)
Jun 2014
-
$1.17 B(-10.8%)
Mar 2014
-
$1.32 B(+4.5%)
Dec 2013
$1.26 B(+16.2%)
$1.26 B(-0.1%)
Sep 2013
-
$1.26 B(+8.1%)
Jun 2013
-
$1.17 B(+1.3%)
Mar 2013
-
$1.15 B(+6.2%)
Dec 2012
$1.08 B(+14.3%)
$1.08 B(+2.2%)
Sep 2012
-
$1.06 B(+5.1%)
Jun 2012
-
$1.01 B(-1.5%)
Mar 2012
-
$1.02 B(+8.0%)
Dec 2011
$948.49 M
$948.49 M(-12.6%)
DateAnnualQuarterly
Sep 2011
-
$1.08 B(+8.2%)
Jun 2011
-
$1.00 B(+8.5%)
Mar 2011
-
$924.21 M(+4.6%)
Dec 2010
$883.89 M(+35.4%)
$883.89 M(+5.1%)
Sep 2010
-
$840.73 M(+7.5%)
Jun 2010
-
$782.30 M(+7.4%)
Mar 2010
-
$728.25 M(+11.5%)
Dec 2009
$653.01 M(+17.6%)
$653.01 M(+2.1%)
Sep 2009
-
$639.56 M(+5.7%)
Jun 2009
-
$604.98 M(+4.8%)
Mar 2009
-
$577.28 M(+4.0%)
Dec 2008
$555.33 M(+87.7%)
$555.33 M(+32.7%)
Sep 2008
-
$418.59 M(+15.2%)
Jun 2008
-
$363.41 M(+11.3%)
Mar 2008
-
$326.43 M(+10.4%)
Dec 2007
$295.79 M(+44.6%)
$295.79 M(+40.5%)
Sep 2007
-
$210.54 M(+17.6%)
Jun 2007
-
$179.00 M(+10.3%)
Mar 2007
-
$162.35 M(-20.7%)
Dec 2006
$204.61 M(-25.6%)
$204.61 M(-25.6%)
Sep 2006
-
$275.05 M(-8.2%)
Jun 2006
-
$299.52 M(+5.0%)
Mar 2006
-
$285.29 M(+3.7%)
Dec 2005
$275.10 M(+43.6%)
$275.10 M(+15.4%)
Sep 2005
-
$238.36 M(+9.9%)
Jun 2005
-
$216.80 M(+6.6%)
Mar 2005
-
$203.31 M(+6.1%)
Dec 2004
$191.64 M(+14.2%)
$191.64 M(+6.9%)
Sep 2004
-
$179.34 M(+5.1%)
Jun 2004
-
$170.59 M(+3.4%)
Mar 2004
-
$165.05 M(-1.6%)
Dec 2003
$167.76 M(-2.3%)
$167.76 M(-1.1%)
Sep 2003
-
$169.55 M(+0.0%)
Jun 2003
-
$169.47 M(+0.7%)
Mar 2003
-
$168.31 M(-1.9%)
Dec 2002
$171.66 M(-12.6%)
$171.66 M(-1.4%)
Sep 2002
-
$174.11 M(-6.4%)
Jun 2002
-
$186.04 M(-2.5%)
Mar 2002
-
$190.80 M(-2.8%)
Dec 2001
$196.40 M(-16.3%)
$196.40 M(-3.5%)
Sep 2001
-
$203.57 M(-4.7%)
Jun 2001
-
$213.59 M(-5.0%)
Mar 2001
-
$224.79 M(-4.2%)
Dec 2000
$234.74 M(+337.9%)
$234.74 M(-3.3%)
Sep 2000
-
$242.77 M(+111.5%)
Jun 2000
-
$114.81 M(-7.1%)
Mar 2000
-
$123.58 M(+130.6%)
Dec 1999
$53.60 M(+221.0%)
$53.60 M(-9.8%)
Sep 1999
-
$59.40 M(+1.9%)
Jun 1999
-
$58.30 M(+276.1%)
Mar 1999
-
$15.50 M
Dec 1998
$16.70 M
-

FAQ

  • What is United Therapeutics annual book value?
  • What is the all time high annual book value for United Therapeutics?
  • What is United Therapeutics annual book value year-on-year change?
  • What is United Therapeutics quarterly book value?
  • What is the all time high quarterly book value for United Therapeutics?
  • What is United Therapeutics quarterly book value year-on-year change?

What is United Therapeutics annual book value?

The current annual book value of UTHR is $5.98 B

What is the all time high annual book value for United Therapeutics?

United Therapeutics all-time high annual book value is $5.98 B

What is United Therapeutics annual book value year-on-year change?

Over the past year, UTHR annual book value has changed by +$1.19 B (+24.77%)

What is United Therapeutics quarterly book value?

The current quarterly book value of UTHR is $6.10 B

What is the all time high quarterly book value for United Therapeutics?

United Therapeutics all-time high quarterly book value is $6.10 B

What is United Therapeutics quarterly book value year-on-year change?

Over the past year, UTHR quarterly book value has changed by +$388.80 M (+6.81%)